FR2427097A1 - Medicament sous la forme d'une solution aqueuse sterile stable de cisplatine - Google Patents
Medicament sous la forme d'une solution aqueuse sterile stable de cisplatineInfo
- Publication number
- FR2427097A1 FR2427097A1 FR7905349A FR7905349A FR2427097A1 FR 2427097 A1 FR2427097 A1 FR 2427097A1 FR 7905349 A FR7905349 A FR 7905349A FR 7905349 A FR7905349 A FR 7905349A FR 2427097 A1 FR2427097 A1 FR 2427097A1
- Authority
- FR
- France
- Prior art keywords
- cisplatin
- aqueous solution
- medicinal product
- stable aqueous
- sterile stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention a trait au domaine de la chimie médicale. Elle concerne une solution aqueuse stérile stable de cisplatine dans un récipient scellé tel qu une ampoule ou une fiole sous une forme posologique unitaire propre à l'administration intraveineuse à l'homme, renfermant le cisplatine à une concentration d'environ 0,1 à environ 1,0 mg/ml et à un pH compris dans la plage de 2,0 à 3,0, de préférence égal à environ 2,5. Cette solution peut aussi contenir du chlorure de sodium et du mannitol. Application à la chimiothérapie du cancer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91032578A | 1978-05-30 | 1978-05-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2427097A1 true FR2427097A1 (fr) | 1979-12-28 |
FR2427097B1 FR2427097B1 (fr) | 1982-11-19 |
Family
ID=25428626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7905349A Granted FR2427097A1 (fr) | 1978-05-30 | 1979-03-01 | Medicament sous la forme d'une solution aqueuse sterile stable de cisplatine |
Country Status (32)
Country | Link |
---|---|
JP (1) | JPS54157817A (fr) |
AR (1) | AR218134A1 (fr) |
AT (1) | AT362052B (fr) |
AU (1) | AU519873B2 (fr) |
BE (1) | BE874596A (fr) |
CA (1) | CA1119954A (fr) |
CH (1) | CH619141A5 (fr) |
CS (1) | CS226002B2 (fr) |
CY (1) | CY1159A (fr) |
DD (1) | DD142293A5 (fr) |
DE (1) | DE2906700C2 (fr) |
DK (1) | DK149192C (fr) |
ES (1) | ES478272A1 (fr) |
FI (1) | FI66121C (fr) |
FR (1) | FR2427097A1 (fr) |
GB (1) | GB2021946A (fr) |
HK (1) | HK37982A (fr) |
HU (1) | HU177557B (fr) |
IE (1) | IE48177B1 (fr) |
IL (1) | IL56540A (fr) |
IT (1) | IT1116893B (fr) |
KE (1) | KE3230A (fr) |
LU (1) | LU81056A1 (fr) |
MY (1) | MY8300152A (fr) |
NL (1) | NL191108C (fr) |
NO (1) | NO149914C (fr) |
NZ (1) | NZ189556A (fr) |
PH (1) | PH18056A (fr) |
PT (1) | PT69207A (fr) |
SE (1) | SE445172B (fr) |
SU (1) | SU1192596A3 (fr) |
ZA (1) | ZA79395B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302446A (en) * | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
CA1162479A (fr) * | 1980-03-31 | 1984-02-21 | Murray A. Kaplan | Compose pharmaceutique contenant du cisplatine |
JPS5851959B2 (ja) * | 1980-06-11 | 1983-11-19 | 呉羽化学工業株式会社 | プラチナ化合物とその医薬組成物 |
DE3046927A1 (de) | 1980-12-11 | 1982-07-15 | Josef Dipl.-Chem.Dr.rer.nat. 1000 Berlin Klosa | 8-dialkylaminoalkylaether-coffein-platin-komplexe , verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
DE3305248A1 (de) * | 1983-02-16 | 1984-08-16 | Degussa Ag, 6000 Frankfurt | Verfahren zur herstellung von reinem cis-platin-(ii)-diammin-dichlorid |
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
GB8501354D0 (en) * | 1985-01-18 | 1985-02-20 | Ici Plc | Effecting gas-liquid contact |
IL85790A0 (en) * | 1988-03-20 | 1988-09-30 | Abic Ltd | Solution of carboplatin |
FI895340A0 (fi) * | 1988-11-14 | 1989-11-09 | Bristol Myers Squibb Co | Hypertonisk cisplatin-loesning. |
WO1990008768A1 (fr) * | 1989-02-01 | 1990-08-09 | Institut Fizicheskoi Khimii Imeni L.V.Pisarzhevskogo Akademii Nauk Ukrainskoi Ssr | Derives de platine (p) avec du methylsilicone, leur procede d'obtention et produits antitumoraux a base de ces derives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053587A (en) * | 1973-04-13 | 1977-10-11 | Research Corporation | Method of treating viral infections |
-
1979
- 1979-01-29 CA CA000320412A patent/CA1119954A/fr not_active Expired
- 1979-01-29 SE SE7900774A patent/SE445172B/sv not_active IP Right Cessation
- 1979-01-30 ZA ZA79395A patent/ZA79395B/xx unknown
- 1979-01-30 DK DK39079A patent/DK149192C/da active
- 1979-01-30 IL IL56540A patent/IL56540A/xx unknown
- 1979-01-31 GB GB7903379A patent/GB2021946A/en not_active Expired - Lifetime
- 1979-01-31 CY CY1159A patent/CY1159A/xx unknown
- 1979-01-31 NO NO790313A patent/NO149914C/no unknown
- 1979-02-01 AU AU43833/79A patent/AU519873B2/en not_active Expired
- 1979-02-01 IE IE194/79A patent/IE48177B1/en not_active IP Right Cessation
- 1979-02-02 PH PH22160A patent/PH18056A/en unknown
- 1979-02-02 NZ NZ189556A patent/NZ189556A/en unknown
- 1979-02-07 FI FI790404A patent/FI66121C/fi not_active IP Right Cessation
- 1979-02-09 PT PT7969207A patent/PT69207A/pt unknown
- 1979-02-09 JP JP1345479A patent/JPS54157817A/ja active Granted
- 1979-02-09 CS CS79901A patent/CS226002B2/cs unknown
- 1979-02-12 HU HU79BI583A patent/HU177557B/hu unknown
- 1979-02-19 NL NL7901283A patent/NL191108C/xx not_active IP Right Cessation
- 1979-02-21 DE DE2906700A patent/DE2906700C2/de not_active Expired
- 1979-03-01 FR FR7905349A patent/FR2427097A1/fr active Granted
- 1979-03-01 CH CH201479A patent/CH619141A5/de not_active IP Right Cessation
- 1979-03-02 ES ES478272A patent/ES478272A1/es not_active Expired
- 1979-03-02 BE BE0/193822A patent/BE874596A/fr not_active IP Right Cessation
- 1979-03-05 AT AT164879A patent/AT362052B/de not_active IP Right Cessation
- 1979-03-09 DD DD79211496A patent/DD142293A5/de not_active IP Right Cessation
- 1979-03-16 LU LU81056A patent/LU81056A1/fr unknown
- 1979-04-05 SU SU792747852A patent/SU1192596A3/ru active
- 1979-05-16 AR AR276542A patent/AR218134A1/es active
- 1979-05-29 IT IT49215/79A patent/IT1116893B/it active
-
1982
- 1982-08-14 KE KE3230A patent/KE3230A/xx unknown
- 1982-08-26 HK HK379/82A patent/HK37982A/xx not_active IP Right Cessation
-
1983
- 1983-12-30 MY MY152/83A patent/MY8300152A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2148400C1 (ru) | Фармацевтически стабильный препарат оксалиплатины | |
KR920700679A (ko) | 비(nasal) 전달용 지질부형제와 그 사용법 | |
ES2076279T3 (es) | Medicamentos que, como principio activo, contienen acidos carboxilicos con contenido en azufre, asi como su empleo para combatir retrovirus. | |
FR2427097A1 (fr) | Medicament sous la forme d'une solution aqueuse sterile stable de cisplatine | |
KR970706830A (ko) | 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2'-dithio-bis (ethanesulfonate) (dimesna) | |
BRPI0206509A8 (pt) | Processo para formular, para administração parenteral, um análogo de epotilona, preparação farmacêutica, processo para formar uma composição farmacêutica para administração parental, composição farmacêutica e uso de um análogo de epotilona na preparação de uma composição farmacêutica para o tratamento de câncer | |
JPS6021570B2 (ja) | ド−パ類の高濃度製剤の製法 | |
KR880007079A (ko) | 레트로비루스에 감염된 환자치료에 있어서의 3'-디옥시티미딘-2'-엔(3'-디옥시-2',3'-디디하이드로티미딘)의 사용법 | |
IE59897B1 (en) | Solutions of oxazaphosphorins having improved stability and process for the preparation thereof | |
ES2390055T3 (es) | Fármaco que contiene ácido(2R)-2-propiloctanoico como principio activo | |
FI95201B (fi) | Menetelmä nestemäisten farmaseuttisten koostumusten valmistamiseksi nenänsisäiseen annosteluun | |
ZA200602689B (en) | Infusion preparation containing (2R)-2-propyloctanoic acid as the active ingredient | |
OA07029A (fr) | Le chlorure de gallium, nouveau médicament anti-cancéreux. | |
KR860000841B1 (ko) | 시스프라틴의 안정화된 농축용액의 제조방법 | |
AU744502B2 (en) | Stable mitoxantron solutions | |
ES2310550T3 (es) | Preparacion liquida acuosa de pranoprofeno. | |
US4915956A (en) | Liquid cisplatin formulations | |
FR2401141A1 (fr) | Nouveaux derives halogenes de prostaglandines et medicaments les contenant | |
WO2009150278A1 (fr) | Composition pharmaceutique de melphalan | |
JPH03130226A (ja) | 1つより多いエチレンイミン基を有する抗新生物性化合物用の安定な製薬学的配合及び方法 | |
FR2374036A1 (fr) | Compositions pharmaceutiques contenant de la 3-phenoxypyridine | |
CA2425367A1 (fr) | Formulations d'oct | |
CA1262686A (fr) | Compose pour soulager les nausees et les vomissements | |
US6818662B2 (en) | Pharmaceutical composition | |
JP2004315470A (ja) | ヨウ化ナトリウム含有製剤 |